Corindus Announces Results of First-in-Human Clinical Study of CorPath(R) 200 System
NATICK, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics (www.corindus.com) announced the results of the first clinical study of the CorPath® 200 System and invites attendees of the Transcatheter Cardiovascular Therapeutics (TCT) 2010 conference (September 21-25 in Washington, DC) to experience firsthand the CorPath 200 System.